Scinovex
articleTop 1% cited

Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Journal of Neurochemistry · 1989 · Vol. 52(6) · pp. 1830–1836
David T. DexterF. R. WellsAlyssa LeeF. AgidYves AgidP. JennerC. D. Marsden

Abstract

Levels of iron, copper, zinc, manganese, and lead were measured by inductively coupled plasma spectroscopy in parkinsonian and age-matched control brain tissue. There was 31-35% increase in the total iron content of the parkinsonian substantia nigra when compared to control tissue. In contrast, in the globus pallidus total iron levels were decreased by 29% in Parkinson's disease. There was no change in the total iron levels in any other region of the parkinsonian brain. Total copper levels were reduced by 34-45% in the substantia nigra in Parkinson's disease; no difference was found in the other brain areas examined. Zinc levels were increased in substantia nigra in Parkinson's disease by 50-54%, and the zinc content of the caudate nucleus and lateral putamen was also raised by 18-35%. Levels of manganese and lead were unchanged in all areas of the parkinsonian brain studied when compared to control brains, except for a small decrease (20%) in manganese content of the medial putamen. Increased levels of total iron in the substantia nigra may cause the excessive formation of toxic oxygen radicals, leading to dopamine cell death.

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsTrace Elements in HealthSubstantia nigraPutamenGlobus pallidusParkinson's diseaseChemistryCaudate nucleusInternal medicineEndocrinologyManganeseBasal ganglia

MeSH terms

AgedAged, 80 and overBrainFemaleHumansIonsIronMaleMetalsParkinson DiseaseSubstantia NigraTissue Distribution
Citations
1,141
FWCI
24.12
field-weighted impact
References
30
Percentile
100%
vs. same field & year
Citations per year
Cited by
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Annual Review of Neuroscience · 1999 · 1,393 citations
The epidemiology of Parkinson's disease: risk factors and prevention
The Lancet Neurology · 2016 · 1,779 citations
Role of GPX4 in ferroptosis and its pharmacological implication
Free Radical Biology and Medicine · 2018 · 1,452 citations
Oxidative stress in Parkinson's disease
Annals of Neurology · 2003 · 2,042 citations
Cytotoxic and genotoxic potential of dopamine
Journal of Neuroscience Research · 1999 · 476 citations
Reactive Oxygen Species and the Central Nervous System
Journal of Neurochemistry · 1992 · 2,941 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.